Monitoring the Cash and IP at the California Stem Cell Agency
The $3 billion California stem cell agency appears unlikely to make any changes in who gets the cash from any commercial products that its research grants help finance despite recommendations from the Institute of Medicine(IOM).
The subject will come up next Wednesday during a meeting of the intellectual property subcommittee of the governing board of th…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.